VPS Healthcare was established in 2007 starting with LLH Hospital in Abu Dhabi which triggered an exponential growth across the healthcare sector. Fast forward to 2011 when LIFEPharma was founded, the ambition to conquer the global market of pharmaceutical formulation was born.
With this vision in mind, LIFEPharma purchased a manufacturing facility located in the Jebel Ali Free Zone from a local player in order to expand its offering. This facility had been out of use for more than 3 years and LIFEPharma took on the challenge of renovation, upgrading of technology and the renewal of registration.
At the time it was purchased, the manufacturing facility had a steady capacity of 300 million tablets, 50 million capsules and 15 million liquids. As a result of the renovation work completed by LIFEPharma and the implementation of American and European technology in the manufacturing process, capacity was increased to 1 billion tablets, 300 million capsules and 150 million liquids.
Pharmaceutical formulation is a long gestation business as it requires plant and product approval by each and every country it operates in, particularly the one it is based in. By meeting strict international requirements along with escalating production, LIFEPharma gained access to do business in Europe, USA, Brazil, Russia, Mexico, China, Japan, Korea, India, Australia, South Africa, and Saudi Arabia.
Today, LIFEPharma has a rich client base of more than 80 customers globally, including various multinational companies. The completion, by late 2018 of a state-of-the-art Oncology Formulation facility, based in KIZAD, will firmly cement LIFEPharma as a multi-faceted, global pharmaceutical company for the future.